Cargando…
Hydroxychloroquine Therapy Led to the Diagnosis of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in an Elderly Patient with COVID-19 Involvement: A Case Report and Review of the Literature
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common RBC abnormality, affecting 400 million people globally. Neonatal jaundice, hemolytic anemia, icteric skin, dark urine, and fever are usually the primary signs of this condition, which is generally diagnosed between the ages of in...
Autores principales: | Taghizadeh-Sarvestani, Razieh, Reihani, Hamid, Ghanei-Shahmirzadi, Ali, Keshtkar, Alireza, Yazdanpanahi, Parsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550493/ https://www.ncbi.nlm.nih.gov/pubmed/36225227 http://dx.doi.org/10.1155/2022/4749424 |
Ejemplares similares
-
Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review
por: Onori, Maria Elisabetta, et al.
Publicado: (2021) -
Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population
por: Hue, Nguyen Thi, et al.
Publicado: (2009) -
Next generation sequencing (NGS) in glucose-6-phosphate dehydrogenase (G6PD) deficiency studies
por: Bogari, Neda M.
Publicado: (2016) -
Glucose-6-phosphate Dehydrogenase (G6PD) A-Variant Frequency and Novel Polymorphism in Haiti
por: Vincent, Jeanne P, et al.
Publicado: (2022) -
Genotypic and phenotypic characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Guangzhou, China
por: Li, Ziyan, et al.
Publicado: (2023)